SMT202300340T1 - Terapia di infezioni da papillomavirus umano ad alto rischio - Google Patents

Terapia di infezioni da papillomavirus umano ad alto rischio

Info

Publication number
SMT202300340T1
SMT202300340T1 SM20230340T SMT202300340T SMT202300340T1 SM T202300340 T1 SMT202300340 T1 SM T202300340T1 SM 20230340 T SM20230340 T SM 20230340T SM T202300340 T SMT202300340 T SM T202300340T SM T202300340 T1 SMT202300340 T1 SM T202300340T1
Authority
SM
San Marino
Prior art keywords
therapy
human papillomavirus
risk human
papillomavirus infections
infections
Prior art date
Application number
SM20230340T
Other languages
English (en)
Italian (it)
Inventor
Norbert Fuchs
Original Assignee
Selo Medical Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selo Medical Gmbh filed Critical Selo Medical Gmbh
Publication of SMT202300340T1 publication Critical patent/SMT202300340T1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SM20230340T 2018-08-28 2019-08-28 Terapia di infezioni da papillomavirus umano ad alto rischio SMT202300340T1 (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18191289.0A EP3616693A1 (en) 2018-08-28 2018-08-28 Therapy of high-risk human papillomavirus infections
EP19765421.3A EP3843715B1 (en) 2018-08-28 2019-08-28 Therapy of high-risk human papillomavirus infections
PCT/EP2019/072926 WO2020043762A1 (en) 2018-08-28 2019-08-28 Therapy of high-risk human papillomavirus infections

Publications (1)

Publication Number Publication Date
SMT202300340T1 true SMT202300340T1 (it) 2023-11-13

Family

ID=63442535

Family Applications (1)

Application Number Title Priority Date Filing Date
SM20230340T SMT202300340T1 (it) 2018-08-28 2019-08-28 Terapia di infezioni da papillomavirus umano ad alto rischio

Country Status (25)

Country Link
US (2) US20210299163A1 (https=)
EP (2) EP3616693A1 (https=)
JP (1) JP7420791B2 (https=)
CN (1) CN112584828A (https=)
AR (1) AR116027A1 (https=)
AU (1) AU2019332079B2 (https=)
BR (1) BR112021003360A2 (https=)
CA (1) CA3107691C (https=)
CL (1) CL2021000197A1 (https=)
EA (1) EA202190441A1 (https=)
ES (1) ES2958808T3 (https=)
GE (2) GEAP202215586A (https=)
HR (1) HRP20231470T1 (https=)
HU (1) HUE064691T2 (https=)
IL (1) IL281080B2 (https=)
MA (1) MA53482B1 (https=)
MD (1) MD3843715T2 (https=)
MX (1) MX2021002310A (https=)
PL (1) PL3843715T3 (https=)
RS (1) RS64916B1 (https=)
SM (1) SMT202300340T1 (https=)
TW (1) TWI827652B (https=)
UA (1) UA127632C2 (https=)
WO (1) WO2020043762A1 (https=)
ZA (1) ZA202100375B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3875083A1 (en) * 2020-03-03 2021-09-08 Selo Medical GmbH Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2245301C2 (ru) 2000-05-10 2005-01-27 Окофарм Форшунгс-Унд Энтвиклюнгс-Гмбх Способ уменьшения площади поверхности диоксида кремния
AT412758B (de) 2000-06-05 2005-07-25 Vis Vitalis Lizenz & Handels Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen
AT412448B (de) 2001-02-13 2005-03-25 Vis Vitalis Lizenz & Handels Verwendung von selenhältigen präparaten
AT412703B (de) * 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
AT511159A1 (de) * 2011-02-16 2012-09-15 Selo Medical Gmbh Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen

Also Published As

Publication number Publication date
CN112584828A (zh) 2021-03-30
CA3107691A1 (en) 2020-03-05
JP7420791B2 (ja) 2024-01-23
JP2021536454A (ja) 2021-12-27
GEP20227432B (en) 2022-10-25
EA202190441A1 (ru) 2021-06-15
MD3843715T2 (ro) 2023-12-31
AU2019332079B2 (en) 2024-08-29
CA3107691C (en) 2024-10-29
EP3616693A1 (en) 2020-03-04
RS64916B1 (sr) 2023-12-29
IL281080A (en) 2021-04-29
EP3843715A1 (en) 2021-07-07
WO2020043762A1 (en) 2020-03-05
IL281080B1 (en) 2024-08-01
HUE064691T2 (hu) 2024-04-28
US20250281524A1 (en) 2025-09-11
ZA202100375B (en) 2024-08-28
TWI827652B (zh) 2024-01-01
AR116027A1 (es) 2021-03-25
BR112021003360A2 (pt) 2021-05-11
EP3843715B1 (en) 2023-09-13
PL3843715T3 (pl) 2024-02-19
MA53482B1 (fr) 2023-11-30
UA127632C2 (uk) 2023-11-08
MA53482A (fr) 2021-07-07
ES2958808T3 (es) 2024-02-15
MX2021002310A (es) 2021-04-28
IL281080B2 (en) 2024-12-01
US20210299163A1 (en) 2021-09-30
HRP20231470T1 (hr) 2024-03-01
EP3843715C0 (en) 2023-09-13
TW202023534A (zh) 2020-07-01
CL2021000197A1 (es) 2021-09-20
AU2019332079A1 (en) 2021-02-11
GEAP202215586A (en) 2022-06-27

Similar Documents

Publication Publication Date Title
PL4331584T3 (pl) Zastosowania lecznicze deuterowanych pochodnych lanifibranoru
GB201804514D0 (en) Treatment of pyroptosis
IL272937A (en) Preparations and methods for the treatment of diseases involving fibrosis
IL277129A (en) Human papillomavirus vaccines and their uses
ZA201906238B (en) New therapeutical use of h3-ligands
GB201805100D0 (en) Treatment of sarcopenic diseases
GB201804515D0 (en) Treatment of necroptosis
ZA202106250B (en) Therapeutic uses of dulaglutide
PT3833378T (pt) Tratamento de verrugas
EP3193946A4 (en) Saccharide analogs and agents for the diagnosis and therapy of bacterial infections
PL3843715T3 (pl) Terapia zakażeń wirusem brodawczaka ludzkiego wysokiego ryzyka
IL268187A (en) Use of Snickepok to treat stroke
ZA201904694B (en) Medical device for the treatment of hpv cutaneous infections
GB201812861D0 (en) Methods of administering therapy
EP3094330A4 (en) Treatment of crohn's disease using low doses of laquinimod
IL281969A (en) New medical use of oxalate-reducing bacteria
ZA201904327B (en) Treatment of skin conditions
HK40038400A (en) Treatment of infectious disease
GB201811912D0 (en) Treatment of disease
GB201811911D0 (en) Treatment of disease
GB201810974D0 (en) Treatment of disease
GB201909438D0 (en) Treatment of diseases
HK40032171A (en) Combination treatment of sarcoglycanopathies
HK40027652A (en) Treatment of neuroinflammatory disease
AU2017901180A0 (en) Treatment of respiratory infection